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(57) ABSTRACT 
The instant invention pertains generally to a method and 
apparatus for rapidly detecting nerve agents, 
organophosphates, and other chemical warfare agents. A 
sensor has been developed that can be used to rapidly detect 
multiple analytes such as organic compounds. Analytes can 
be detected by monitoring changes in the optical properties 
of the absorbance and/or fluorescence spectra of highly 
colored heterocyclic compounds such as porphyrins or 
related compounds such as phthalocyanines. The result is a 
real-time monitor that is suitable for use in situations where 
encounter with chemical warfare agents is possible. 
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BROAD SPECTRUM BIO-DETECTION OF 
NERVE AGENTS, ORGANOPHOSPHATES, 
AND OTHER CHEMICAL WARFARE 
AGENTS 
RELATED APPLICATIONS 
This application is a continuation-in-part of pending U.S. 
application Ser. No. 09/487,559 filed Jan. 19, 2000 now 
abandoned, which application claims the benefit of U.S. 
Provisional Application Ser. No. 60/116,504, filed on Jan. 
20, 1999, the disclosures of which are incorporated herein 
by reference. 
STATEMENT REGARDING FEDERALLY 
SPONSORED RESEARCH 
The instant invention was partially supported through 
grants from the U.S. Navy (N00014-92-J-1096) and the U.S. 
Army (DAAD 05-98-P-1946). The U.S. government may 
have rights in this invention. 
TECHNICAL FIELD 
The present invention relates to real-time or near real-time 
detection in gases or fluids of nerve agents of the sort 
commonly encountered in chemical warfare agents. 
BACKGROUND 
Often referred to as the "poor man's nuclear weapon", 
chemical and biological weapons of war are so named 
because they cost much less than real nuclear weapons to 
develop, do not require a high level of technology to 
produce, and can potentially kill enormous numbers of 
people. Indeed, unlike nuclear weapons, which require a 
large, specialized, and costly scientific-industrial base, 
chemical and biological agents can be made with commer-
cial equipment generally available to any country. Weapons 
5 
2 
biological attack can be completed before those on the 
ground have realized that it has occurred, or even take place 
entirely covertly, the effects being confused with a natural 
outbreak of disease. 
Biological agents are odorless, tasteless, and when dis-
persed in an aerosol cloud, are invisible to the human eye 
because the particle size of the aerosol is extremely small-
as small as 1 to 5 micrometers or microns. Weight-for-
weight, biological weapons are hundreds to thousands of 
10 
times more potent than the most lethal chemical weapon, 
meaning that even small amounts (e.g., a few kilograms) 
could be used with devastating effect, whereas hundreds or 
thousands of tons of chemical agents could be required for 
militarily significant operations. 
15 
Among lethal chemical warfare agents, nerve agents have 
played a dominant role since the Second World War. Nerve 
agents are so-called because they affect the transmission of 
nerve impulses within the nervous system. Nerve agents 
belong chemically to the group of organo-phosphorus 
("OP", hereinafter) compounds. OP compounds are stable, 
20 easily dispersed, highly toxic, and take effect rapidly both 
when absorbed through the skin and via respiration. They 
can be manufactured by means of fairly simple chemical 
techniques and the raw materials to manufacture them are 
inexpensive and generally readily available. Sarin, one of 
25 the more familiar nerve agents, dates from the Second World 
War and is considered a "classic" substance. In the mid-
1950's, however, a group of more stable nerve agents known 
was the V-agents were developed, with VX being one of the 
more successful variants. These later-day chemical weapons 
30 are approximately ten-fold more poisonous than sarin and 
are thus among the most toxic substances ever synthesized. 
Nerve agents in pure state are colorless liquids with 
volatiles that vary depending on the particular compound. 
The consistency of VX may be likened to a non-volatile oil 
35 and is therefore classified as belonging to the group of 
persistent chemical warfare agents. It enters the body mainly 
through direct contact with the skin. Sarin is at the opposite 
extreme, being a relatively volatile liquid ( comparable with, of this sort are especially attractive for use by developing 
countries against super powers, as they tend to level the 
playing field in struggles against these better armed and 40 
trained opponents. The use of biological and chemical 
weapons of mass destruction is banned by international 
treaty, but reports of suspected and confirmed use continue. 
e.g., water), and is mainly taken up through the respiratory 
organs. 
The nerve agent, either as a gas, aerosol or liquid, enters 
the body through inhalation or through the skin. Poisoning 
may also occur through consumption of liquids or foods 
contaminated with nerve agents. The route through which 
the poison enters the body largely determines the time 
required for the nerve agent to begin having an effect. It also 
Biological weapons can be produced from widely avail-
able pathogens which may be procured for legitimate bio- 45 
medical research or obtained from soil or infected animals 
and humans. Moreover, many of the infectious diseases 
associated with biological warfare are endemic to most of 
the states suspected of developing a biological weapon 
capability. Biological agents are thus both cheap and easy to 
obtain: in effect, any nation with a basic pharmaceutical 
industry---{)r even a facility such as a brewery-has the 
capability of producing biological weapons. 
Biological agents contain either living organisms or their 
derivatives, such as toxins, which cause disease or death in 
humans, animals, or food crops. Living organisms multiply 
within the living targets to produce their effects, whereas 
toxins cannot reproduce themselves. Toxins are generally 
more lethal, and act relatively quickly causing incapacitation 
or death within minutes or hours. Living organisms 
(microbial pathogens), require incubation periods of from 24 
hours to 6 weeks between infection and appearance of 
symptoms. This incubation period places limits on their 
battlefield utility, but it also means that biological weapons 
can continue to have a significant impact many weeks after 
the initial attack (e.g., by causing a long-term pandemic). 
Likewise, this delayed incubation period may mean that a 
influences the symptoms developed and, to some extent, the 
sequence of the different symptoms. Generally, poisoning 
takes place more rapidly when the agent is absorbed through 
50 the respiratory system than when it enters via other routes 
such as the skin. This is because the lungs contain numerous 
blood vessels which provide for rapid assimilation and 
transmission to the target organs. Nerve agents are more or 
less fat-soluble and can penetrate the outer layers of the skin. 
55 However, it takes some time before the poison reaches the 
deeper blood vessels. Consequently, the first symptoms may 
not appear until 20-30 minutes after the initial exposure. 
Chemically, nerve agents act by binding to an enzyme in the 
body of the victim, acetylcholinesterase, which inhibits this 
60 vital enzyme's normal biological activity in the cholinergic 
nervous system. Acetylcholinesterase ("AChE") terminates 
nerve impulse transmission at cholinergic synapses by 
hydrolyzing the neurotransmitter acetylcholine to acetate 
and choline. Organophosphate compounds such as insecti-
65 cides and nerve agents inhibit AChE, which inhibition 
results in a build up of acetylcholine, thereby causing 
constant transmission of nerve signals. 
US 6,821,738 B2 
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Most recent research in the area of chemical and biologi-
cal weapons has been focused on the detection and treatment 
of exposed individuals rather than the creation of new 
agents. Because the length of time that an individual is 
exposed to the agent can be determinative of the likelihood 5 
of successful treatment, rapid recognition that an exposure 
has occurred may mean the difference between life and 
death. Of course, this recognition/identification time 
includes not only the time required to perform the necessary 
diagnostic or chemical tests, but also the time required to 10 
move the victim or exposed item to a testing station or 
facility ( or to move the testing unit to the victim, in some 
cases). 
4 
porphyrins or other colorimetric indicators complexed with 
the protein. In brief, this embodiment of the instant inven-
tion detects an analyte by measuring the conformational 
change of its specific binding protein. 
The instant invention is founded on the observation that 
complexes of protein with colorimetric compounds can be 
used to detect the presence of very low concentrations of 
hazardous or chemical warfare agents. Changes in the spec-
trum of a properly chosen colorimetric compound can be 
used as a "real-time" indicator to detect the presence of a 
broad range of dangerous substances such as nerve agents, 
organophosphates, and other chemical warfare agents. By 
way of general explanation and according to a first preferred 
embodiment, it is well known, and will be further discussed Certainly, there are any number of methods for detecting 
specific oganophosphate compounds in water or air. 
However, the methods suggested heretofore for are either 
too slow to make them useful for real time detection, or too 
bulky to be easily transported to a location near the front 
lines, where an attack would normally first be registered. For 
example, one common method of determining the presence 
of an OP compound is to measure the biochemical activity 
of acetylcholinesterase; if OP is present, the activity per 
enzyme molecule present decreases. However, this method 
15 in the following narrative, that the electron distribution in a 
colorimetric compound is altered by its immediate environ-
ment. Changes in electron distribution result in correspond-
ing changes in the spectrum of the colorimetric indicator. 
Thus, an indicator for use in detecting hazardous compounds 
20 may be created by monitoring specific lights wavelengths in 
the spectrum of a colorimetric compound of choice. Further, 
because of the multiplicity of absorbance bands in various of 
these indicators, unique spectral "signatures" may be devel-
is very slow and it might require days to get the sample to 
the lab and complete the tests. Additionally, even if conven- 25 
tional transportable units were fast enough to make them 
useful in real-time, they are too bulky to be distributed to and 
carried by every soldier which would be, of course, the best 
method of distribution. Further, most traditional methods of 
detecting nerve-type agents are designed to respond to one 30 
(or a few) specific compounds, which creates certain risks 
for in-field use, where the particular nerve gas variant might 
be different than expected 
oped for use in subsequent detection. 
Measurements of the optical changes in the colorimetric 
indicator are preferably made using both absorbance and 
fluorescence spectroscopy in the visible ( 400-800 nm) 
region. However, rather than attempt to directly sense 
changes in the spectrum of the indicator, difference spectra 
are preferably used instead, a difference spectrum being 
defined to be the spectrum of the indicator following expo-
Heretofore, as is well known in the chemical and biologi-
cal warfare arts, there has been a need for a method and 
apparatus that provides for rapid detection of nerve agents 
such as organophosphate compounds ("OP" compounds, 
hereinafter). This method should operate quickly and reli-
ably to provide identification at the earliest possible 
moment, preferably in real-time or nearly so. It should work 40 
to detect these compounds in air or water and be portable 
and inexpensive enough to be issued to each individual who 
sure to an analyte minus the spectrum of the indicator prior 
to exposure. Wavelength shifts as small as 1-2 nm and 
absorbance changes down to or below 0.00SA can be 
35 identified using the difference spectrum, thereby making it 
possible to identify over 7700 different analytes and quantify 
their concentration levels down to the 10-9 M range. 
is at risk of exposure. Finally, it should a broad band detector 
which is responsive to a wide variety of OP compounds. 
Accordingly, it should now be recognized, as was recog- 45 
nized by the present inventor, that there exists, and has 
existed for some time, a very real need for an invention that 
would address and solve the above-described problems. 
Before proceeding to a description of the present 
50 
invention, however, it should be noted and remembered that 
the description of the invention which follows, together with 
the accompanying drawings, should not be construed as 
limiting the invention to the examples ( or preferred 
embodiments) shown and described. This is so because 
55 
those skilled in the art to which the invention pertains will 
be able to devise other forms of this invention within the 
ambit of the appended claims. 
Binding of substrate as well as inhibitors of enzymes may 
induce conformational changes in the enzyme. As is 
described hereinafter, changes in protein conformation 
induced by a substrate/inhibitor can be detected by porphy-
rins. More particularly, the change in conformation of ace-
tylcholine esterase (the principal target for nerve agents and 
pesticides) upon binding of inhibitors is detected by colo-
rimetric indicators such as porphyrins. Enzymes can be 
immobilized and complexed with porphyrins to make a 
solid-state monolayer reactive thin film sensor surface 
whose optical properties can readily be detected. 
Additionally, and according to another preferred 
embodiment, there is provided a method and apparatus for 
the detection of nerve agents, OP compounds, and other 
molecules, including pesticides, which utilizes a reversible 
competitive inhibitor in combination with changes in the 
spectrum of the detecting materials to create a real-time 
sensor. More specifically, according to a preferred 
embodiment, an AChE-based biosensor is created by bind-
ing to the AChE molecule a porphyrin which inhibits it and 
which reversibly binds at the active site where substrate 
SUMMARY OF THE INVENTION 
According to a first preferred aspect of the instant 
invention, there is provided a method for detecting the 
presence of nerve agents, OP compounds, and other 
molecules, including pesticides by detecting an alteration of 
the electron configuration and spectral properties of porphy-
rins and porphyrin surfaces and, recognizing the changes in 
protein conformation which are evidenced by alteration of 
60 and/or nerve gasses and other inhibitors will bind. One such 
preferred porphyrin is TPPS1 (i.e., monosulfonate tetraphe-
nyl porphyrin). When such a biosensor is exposed to nerve 
agents, etc., the OP compound will displace the selected 
porphyrin, thereby resulting in a change in the spectral 
65 properties of the biosensor. 
According another aspect of the instant invention, there is 
provided an apparatus for detecting materials such as nerve 
US 6,821,738 B2 
5 
agents, pesticides, and OP compounds, which uses real-time 
measurement of the changing spectral characteristics of a 
substrate as an indication of the presence of these materials. 
More particularly, the instant apparatus monitors the chang-
ing optical spectrum of a specially prepared colorimetrically 5 
responsive surface which indicates the presence of materials 
such as organophosphates through changes in its spectrum. 
Broadly speaking, the instant apparatus consists of a light 
source (preferably emitting light in the 400 nm to 800 nm 
range); a colorimetrically responsive surface which is illu-
10 
minated by the irradiating light source; and, an optically 
sensitive detector which is directed toward the illuminated 
surface. In the preferred embodiment, the light source/ 
detector combination operates continuously so that changes 
6 
the instant invention is to utilize changes in the spectra-
graphic properties of a reversible competitive inhibitor as a 
detector for OP and similar compounds. 
The foregoing has outlined in broad terms the more 
important features of the invention disclosed herein so that 
the detailed description that follows may be more clearly 
understood, and so that the contribution of the instant 
inventor to the art may be better appreciated. The instant 
invention is not to be limited in its application to the details 
of the construction and to the arrangements of the compo-
nents set forth in the following description or illustrated in 
the drawings. Rather, the invention is capable of other 
embodiments and of being practiced and carried out in 
various other ways not specifically enumerated herein. 
15 Finally, it should be understood that the phraseology and 
terminology employed herein are for the purpose of descrip-
tion and should not be regarded as limiting, unless the 
specification specifically so limits the invention. 
in the absorptive properties of the detection surface are 
immediately identified. It should be noted that the instant 
invention can be made small enough to take the form of a 
badge or similar device that might be worn continuously by 
at-risk personnel, and this device might also incorporate 
some sort of warning mechanism to notify the wearer the 
20 
instant that OP compounds are detected. However, the 
instant inventor additionally contemplates that the light 
source and detector might be maintained separately from the 
detection surface, with identifying tests being conducted at 
some central location such as a testing station or laboratory. 
25 
In another preferred detection scheme, a biochemically 
active solid-state layer of AChE is deposited on a micro-
scope slide. After exposure to an unknown compound, the 
slide is read via spectroscopy, not by shining light onto the 
face of the slide, but rather preferably by "injecting" light 30 
into the glass slide containing the AChE through an edge of 
the slide. The effect of such delivery is that the incident light 
beam is reflected internally off of each parallel surface of the 
slide. Additionally, as is well known to those of ordinary 
skill in the art, the internally reflected beam extends about ¼ 35 
wavelength (e.g., 100-200 nm depending on the wavelength 
of the incident light) into the surrounding medium through 
the creation of evanescent light waves. The evanescent light 
waves penetrate the detector layer on the surface of the slide 
and interact with the chemicals present thereon. As 40 
described previously, the intensity of light that has interacted 
with the detecting layer is then examined at at least two 
different spectral wavelengths for evidence of the presence 
of an OP compound. Preferably, the light that is supplied to 
the preferred slide embodiment, and which is the source of 45 
the evanescent waves, will be delivered by way of optical 
fibers. 
Among the many agents/analytes which are believed to be 
detectable by the instant invention are "simulants" of chemi-
cal and biological warfare agents: DIMP, DMMP, MPA, 50 
malathion, parathion and tetracain to simulate organo-
phosphate agents such as Sarin or VX; and imidazole, 
methionine, thiodiethanol, cysteine, and other sulfur-
containing organic molecules to simulate mustards. 
In summary, the primary objectives of the instant inven- 55 
tion are three fold. First, to utilize the spectral changes of 
colorimetric indicators such as porphyrins to identify 
chemical/biological agents ( or simulants thereof) at different 
concentrations. In the preferred embodiment, the colorimet-
ric indicator will either be a porphyrin in solution or a 60 
porphyrin immobilized onto a solid surface for use in test 
aqueous samples and samples in air. 
A second object of the instant invention is to exploit the 
conformational changes in acetylcholine esterase and related 
enzymes induced by binding of inhibitors, including nerve 65 
agents, through the monitoring of spectral changes of colo-
rimetric indicators reflective of that change. A third object of 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 contains difference spectra of TPPS plus naphtha-
lene minus TPPS for four different concentrations of naph-
thalene. 
FIG. 2 illustrates difference spectra of glucose oxidase, 
boiled glucose oxidase, and boiled glucose oxidase minus 
glucose oxidase all in the presence of the porphyrin TPPS. 
FIG. 3 contains differences spectra of Trypsin plus Inhibi-
tor (INH) plus TPPS minus Trypsin plus TPPS; Trypsin plus 
TPPS minus TPPS; and, Trypsin plus inhibitor plus TPPS 
minus TPPS. 
FIG. 4 illustrates the spectra that result in the presence of 
TPPS for Gluconolactone, Glucosidase, and Glucosidase 
plus Gluconolactone. The numbers indicate the wavelengths 
at which absorbance is lost/wavelengths at which absor-
bance is gained. 
FIG. 5 contains a simplified schematic of an OP detector 
that implements the method of the instant invention. 
FIG. 6 illustrates an OP detection circuit, wherein a 
fluorescent light source is used. 
FIGS. 7A-7D contain another OP detector schematic. 
FIG. 8 schematically illustrates the conformational 
changes that occur in acetylcholinesterase in the presence of 
an inhibitor such as VX nerve gas. 
DETAILED DESCRIPTION 
The instant disclosure teaches a new approach to the 
detection of OP-type compounds that are commonly used as 
warfare (nerve) agents and are also found in some pesticides, 
etc. The method and apparatus of the instant invention can 
be configured to detect multiple analytes (such as organic 
compounds) in liquid or vapor (air) and operates generally 
by monitoring the optical properties of a chemical that is 
altered by interaction with the OP/agent. In more particular, 
analytes can be detected by monitoring changes in the 
optical properties of the absorbance, reflectance, and/or 
fluorescence spectra of highly colored heterocyclic com-
pounds such as porphyrins or related compounds such as 
phthalocyanines. Further, the instant apparatus and method 
is unique in that it does not require pre-use "calibration" of 
the colorimetric materials or apparatus. Because the instant 
invention continuously monitors the detecting surface/ 
volume and compares its spectrographic properties with 
those of the detecting surface a few moments before, the 
invention disclosed herein is to a large extent self-
calibrating. 
US 6,821,738 B2 
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diphosphoglycerate binds to deoxyhemoglobin at the center 
of symmetry of the tetramer consisting of 2 alpha and 2 beta 
chains in a central cavity far removed from the oxygen-
binding (heme) sites and stabilizes the deoxyhemoglobin 
A fundamental concept underlying the preferred sensor 
design is the change in the 3-dimensional conformation of a 
protein/enzyme when it binds its substrate or specific inhibi-
tor. The binding of substrates to enzyme results in the 
formation of an enzyme-substrate complex (ES complex) 
that has been observed to alter the physical shape of the 
protein as well as the optical spectrum of the enzyme. It is 
this change in the optical spectrum that is most important for 
purposes of the instant invention. 
5 T-form quaternary structure by cross-linking the B-chains. 
General Environment of the Instant Invention 
10 
The T-form is less compact than the R-form (oxygenated), a 
clear example of a conformational change induced by a 
non-competitive inhibitor. 
Similarly, binding of glycyltyrosine, a slowly hydrolyzed 
substrate of the enzyme carboxypeptidase A, results in a 
large conformational shift in the active site configuration. 
During the binding, tyrosine-248 moves from the surface to 
15 the active site. This closes the active site and converts it from 
a hydrophilic to a hydrophobic region. Other significant 
OP compounds inhibit the enzyme acetylcholinesterase, 
which breaks the neurotransmitter acetylcholine into acetate 
and choline, by binding at the active site in place of 
acetylcholine. The phosphate group of the OP agents binds 
irreversibly with serine (residue #200) in the active site. It is 
the presence of the serine in the active site of acetylcholine 
esterase (AChE) as well as trypsin and chymotrypsin, 
papain, and other enzymes that puts these enzymes in the 
broad category of "serine proteases or esterases". It is to be 20 
expected, and has been observed, that the inhibitor 
paraoxon-which binds in the same place as 
acetylcholine--{)perates to make the overall shape of AChE 
less ellipsoid. Igarashi, S. and Yotsuyanagi, T. (1993), Ana-
lytica Chimica Acta. 281, 347-351. In other words, a 25 
conformational change occurs upon binding of an inhibitor 
( and most likely the substrate as well). 
Two specific examples of bindings that result in confor-
mational changes are the joining of oxygen to a crystal of 
hemoglobin (Hb) and to hemeproteins. First, the binding of 30 
oxygen to a crystal of hemoglobin (Hb) results in cracking 
of the hemoglobin crystal. The wavelength of native deoxy-
forms of hemoglobin or myoglobin (Mb) is 430 nm; when 
oxygen binds, the wavelength maximum (wavelength at 
which maximum absorbance is observed) shifts to 417 nm. 35 
Table 1 shows the wavelength maxima of Mb/Hb with other 
molecules that resemble oxygen and bind to Hb/Mb in place 
of oxygen. These molecules act as competitive inhibitors by 
binding at the active site of the enzyme in place of the 
substrate. Since the active site is occupied by another 40 
molecule, it cannot bind to or catalyze the reaction with the 
substrate. A similar complex is seen in other ( endogenously 
colored) hemeproteins such as the enzyme cytochrome 
oxidase in mitochondria where the binding of the natural 
substrate (again oxygen) changes the wavelength maximum 45 
of the oxidase from 444 to 430 nm. Similar shifts are seen 
when CO binds in place of oxygen; the wavelength maxima 
at 448 and 604 nm for the reduced form shift to 430 and 590 
nm respectively. 
changes in conformation are also observed. 
Conformation of the protein can be determined several 
ways: the change in size or shape of the protein can be 
measured by alteration of its passage through a porous sieve 
(such as Sephadex); by changes in the rate of electrophoretic 
migration through a meshwork in an electrical field; optical 
measurement of changes in circular dichroism (CD) or 
optical rotatory dispersion (ORD) due to changes in alpha-
helix and beta sheet regions of the protein. Changes in 
conformation can also be detected by changes in the 
fluorescence/absorbance of a "reporter" molecule such as 
anilinonaphthalene sulfonate (ANS) or a molecule whose 
optical characteristics are affected by its environment. 
One class of molecule whose optical characteristics are 
altered by the presence of other molecules including 
proteins-and which is of particular importance for pur-
poses of the instant disclosure-is the porphyrins. As will be 
shown hereinafter, the spectra of porphyrins is altered by the 
presence of numerous organic compounds (e.g., 
naphthalene, benzene, formaldehyde, isopropanol, alcohols, 
amino acids, nucleic acids, etc.) including proteins at micro-
molar or lower concentrations. Thus, porphyrins or similar 
molecules are the preferred colorimetric indicator of nerve-
agents-induced conformational changes for use with the 
instant invention. 
Spectral Properties of Porphyrins 
One explanation for the observed spectral changes in the 
porphyrins is the alteration of pi-electrons of the porphyrins 
TABLE 1 
Changes in Wavelength of Hemoglobin/Myoglobin in the 
Presence of Ligands 
Protein and ligand B-band a-band 
50 (this gives them their intense color) by the analyte mol-
ecules. Because of the spectral alterations due to amino 
acids, changes in the absorbance spectrum of porphyrins by 
proteins (made up of amino acid residues) are both expected 
and observed in practice. An example of this change in the 
55 porphyrin spectrum is shown in FIG. 1, where the wave-
length maximum of tetraphenylporphyrin sulfonate (TPPS) 
changes from 413 nm to 426 nm in the presence of 
naphthalene, indicated by a decrease in absorbance at 
Hemoglobin/myoglobin 430 nm 555 nm 
Oxymyoglobin 417 581 
Oxyhemoglobin 415 577 
CO-hemoglobin 419 568 
Methemoblobin ( oxidized 406 630 
with bound water) 
Binding of an inhibitor to a site other than the active site 
can also result in changes in the conformation of a protein 
enzyme. This sort of binding would characterize a non-
competitive inhibitor, which is one that does not compete 
with substrate for the active site. For example, 2,3-
60 approximately 413 nm as TPPS is changed into the 
naphthalene-TPPS adduct absorbing at 426 nm; in these 
spectra the difference spectrum is shown in which the 
spectrum of TPPS alone is subtracted from the spectrum of 
TPPS in the presence of naphthalene. Shifts in wavelength 
65 maxima are observed with different analytes in either free 
aqueous or immobilized TPPS in either water or air medium. 
Some examples are given in Table 2. 
US 6,821,738 B2 
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TABLE 2 
Changes in Sorel Absorbance of TPPS in Presence of Analytes 
Absorbance Absorbance Immobil-
ANALYTE decrease at (nm) increase (nm) ized Medium 
Isopropanol 431 421 yes air 
acetone 434 423 yes air 
methanol 429 418 yes air 
formaldehyde 431 421 yes air 
ethanol 427 416 yes air 
naphthalene 413 426 no H20 
benzene 413 419 no H20 
formaldehyde 413 434 no H20 
naphthalene 424 422 yes H20 
tyrosine 413 423 no H20 
tryptophan 413 425 no H20 
glycine 409/415 split no peak no H20 
methionine no loss 413 no H20 
adenine 411 421 no H20 
thymine 411 no peak no H20 
Changes in the Q- (alpha) bands not listed here. 
The shift in wavelength maximum is also different 




Change in Wavelength of soluble TPPS by Proteins 













Boiling a protein "denatures" it, changing its "natural" 
structure, just as frying an egg denatures the protein as 
witnessed by a change in the nature of the white and the 
yolk. As seen in FIG. 2, boiling denatures glucose oxidase. 
In the presence of normal glucose oxidase, only a small 
decrease in absorbance at 412.5 nm is observed. In the 
presence of boiled glucose oxidase, the absorbance decrease 
at 412.5 nm is larger and a new absorbance peak at 423 nm 
is observed (not observed in "normal" glucose oxidase). If 
TPPS were to experience the same environments in boiled as 
in native glucose oxidase, there would be no difference in 
the spectra of boiled and native protein. A change in spec-
trum indicates that the porphyrin TPPS reflects the change in 
conformation of the protein caused by boiling. 
Porphyrin Properties 
10 
to be affected by the solvent. The basis for these solvent-
induced spectral changes is similar to the basis of the change 
in the wavelengths absorbed by altering the groups substi-
tuting at positions 1-8 on the porphyrin ring. Factors which 
5 cause an increase in pi-electron orbitals at the periphery of 
the porphyrin tend to cause red shifts of the absorbance and 
fluorescence (if present) bands. Red shifts are found to arise 
as a function of the electron affinity of side chain substitu-
ents at positions 1-8. As the electronegativity is increased, 
10 the stability of the metal chelate decreases and absorption/ 
emission bands shift accordingly. As pi electrons are with-
drawn from the periphery, the spectrum blue shifts to shorter 
wavelengths. 
Just as the energy transitions for absorbance of photon 
15 energy are altered, so are the energy transitions involved in 
photon emission of absorbed energy. Thus the fluorescence 
spectra of porphyrins is altered, each having its unique 
spectrum. 
20 Detection of Organic Ligands by Complex 
Formation with Porphyrins 
As a threshold matter, in order to function as a detector for 
purposes of the instant invention, the detector molecule must 
be able to interact with the target analyte(s) and its spectrum 
25 (absorbance, fluorescence, or reflectance) must be altered by 
the interaction. In the preferred embodiment, and for reasons 
set out in more detail below, porphyrins, when combined 
with AChE, are especially suitable for use as the detector 
component of the instant invention. 
30 
A number of publications report the chemical alteration of 
organic molecules by the catalytic activity of porphyrins and 
porphyrin-like heterocyclic compounds. In view of the 
intense light absorbance by these molecules, some of the 
35 
catalytic processes are light-activated and light-dependent; 
others may require the presence of a reductant as well. 
Of particular importance for purposes of the instant 
invention are the spectrographic changes that occur in 
porphyrin catalyzed reactions. The crux of the phenomenon 
40 is that in order for porphyrins to catalyze an organic reaction, 
the porphyrin must bind, "dock" with, or somehow interact 
physically with the organic at least once during the catalytic 
process (a collisional encounter between substrate and 
catalyst). In those cases where a reactant [such as OH-, H+, 
45 electrons, 0 2-, 1,,'i.g02 (singlet oxygen)] may be generated at 
the porphyrin and difuse to the organic molecule, the dif-
fusion distance must be very small ( the lifetime of singlet 
oxygen in H2 0 being on the order of nanoseconds), indi-
cating that the porphyrin and organic are very close together, 
50 probably "docked". 
Porphyrins are nitrogen-containing compounds that are 
derived from the parent molecule tetrapyrroleporphin and 55 
which are very useful for purposes of the instant invention. 
They are classified on the basis of the nature of the side 
chains replacing the hydrogens at positions 1-8; methyl, 
ethyl, vinyl, and propionic acid are common substituents. 
Docking of the organic, analogous to the formation of an 
enzyme-substrate complex, should result in a distortion of 
the electron distribution of both molecules. Since the 
pi-electron distribution of the porphyrins is responsible for 
their intense visible light absorbance, alterations of porphy-
rin spectra upon organic ligation should be seen. This idea 
is consistent with the changes in E and "-max of the Soret 
( 400-450 nm) band (B-band) of the porphyrins by alteration 
of the porphyrin side chain constituents of the porphyrin 
ring, as shown in FIG. 1 and Table 2, and alteration of the 
spectral properties due to solvent polarity and hence differ-
Complexation of porphyrins with metal alters the absor- 60 
bance spectrum of the porphyrins. It is of interest to note that 
the wavelength is dependent on the metal as well as the 
solvent used. In a given solvent, the wavelength maxima of 
the different metal complexes are sufficiently different to 
allow spectrophotometric resolution of the different metal 65 
complexes. The absorbance spectrum and the extinction 
coefficient ( absorptivity) of a metallo-/porphyrins are known 
ences in the electron distribution around the porphyrin plane 
( cf. Table 2). 
Alteration of the spectrophotometric characteristics of 
porphyrins has been reported by, for example, D. Mauzerall 
(Biochem. 4, 1801-1810, 1965) and J. A Shelnutt, J. A, (J. 
of Phys. Chem. 87, 605-616, 1983), the disclosures of which 
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are incorporated herein by reference. In these studies aro-
matic heterocyclic compounds such as phenanthrolines were 
complexed with porphyrin molecules; changes in pi-orbital 
density were observed, leading to changes in visible light 
absorbance, fluorescence, and Raman spectra. 
12 
lengths of about 405 and 426 nm in order to determine 
whether or not the porphyrin has been displaced and, hence, 
whether or not OP compounds are present in the sample. 
Turning now to a discussion of this aspect of the invention 
5 in more detail, as a first step, microscope slides are obtained 
that have been coated with amino groups. Slides sold under 
the trademark "Probe-On" from the company "Fisher Sci-
entific" are particularly suitable for this purpose. 
Close interaction of porphyrins and organics resulting in 
the quenching of porphyrin absorbance and fluorescence 
spectra have been reported. Further, porphyrins have been 
used in the shape-selective separation of aromatics and are 
particularly useful in the separation of fullerenes. Soret "-max 10 
positions have been observed to change in the presence of 
organic polycyclics, the shift in "-max being proportional to 
the energy of association with the porphyrin. This suggests 
that the stronger the interaction between organic and 
porphyrin, the greater the shift in wavelength. 
Alternatively, a plain glass slide might be prepared by 
treating it with a chemical such as 3-aminopropyltriethoxy 
silane, which would "functionalize" its surfaces and result in 
free amino groups that are bound thereto. It should be noted 
that a glass slide is only a preferred choice and, as is 
described more fully below, plastic, silica, quartz, 
15 plexiglass, or many other materials might be used instead. 
The use of porphyrins and phthalocyanines as chemical 
sensor indicators is gaining in popularity. Wavelength shifts 
as colorimetric indicators have been used to sense the 
presence of pentachlorophenol, cysteine and histidine, and 
quinones. The binding of the quinone has been determined 20 
to be via multiple H-bonds between the quinone and the 
OH-naphthyl subgroups of the porphyrin as well as between 
the quinone and the coo- groups of Zn- porphyrin dini-
trobenzoic acid. A gas sensor which measures CO, NO2 , and 
H2S has been designed using metalloporphrin Langmuir-
25 
Blodgett films deposited on a field-effect transistor. Dziri, L., 
Bousaad, S., Tao, N. and, Leblanc, R. M. (1998) Langmuir 
14, 4853-4859. 
Preferably, and for ease in later evaluating the detector, the 
material on which the amino groups are found will be 
optically transparent. 
Given a coated microscope slide as described previously, 
the amino groups present thereon are then preferably reacted 
with glutaraldehyde to form a Schiff's base, which can then 
be used to bind a preferred dendrimer which is sold under 
the trademark "Starburst" by Aldrich Chemical. The trade-
marked dendrimer is preferred because it has 64 amino 
termini, which effectively amplifies the number of binding 
sites by a factor of 64. The 64 amino sites are then reacted 
with glutaraldehyde to form a Schiff's base and then ace-
tylcholineesterase or the desired enzyme is bound. 
Therefore, the net result is a layer of enzyme that is In related work, the photo-induced energy transfer 
between two porphyrins which have been co-deposited as 
solid film on Ti02 has been measured, indicating the ability 
of energy transfer between porphyrins and their near 
( docked) neighbor. Illumination of a donor molecule elicits 
energy changes in the acceptor porphyrin although no elec-
tron transfer occurred, indicating that changes in one mol-
ecule elicit spectral changes in another neighboring acceptor 
molecule. This is similar to the recognition of specific DNA 
sequences using oligonucleotide-derivatized polypyrroles 
30 covalently bound to the glass, in effect, a "sandwich" of 
glass/Starburst/acetylcholineesterase ( or other proteins). In a 
preferred arrangement, as a next step the porphyrin is 
attached to the AChE by preparing a 70 micro molar solution 
of porphyrin in 75% ethanol and placing that mixture on the 
35 slide for about 15 minutes, after which the slide is washed 
and is ready for use as a detector. 
by voltammetry and the interaction of porphyrin-thymidine 
40 
complex with DNA in which the H-bonding of the 
porphyryl-thymidine with adenine results in an 8 nm red 
shift in the porphyrin Soret band. 
Thus, if the above-described AChE detector, i.e., one with 
a suitable porphyrin bound at the active site, is exposed to 
OP or similar compounds, the OP compounds will react with 
the detector material and the attached porphyrin will be 
displaced (i.e., it is a reversible inhibitor). Since, the por-
phyrin is not strongly bound, it is easily displaced from its 
position, thereby providing a means for recognizing when Thus, alteration in the electron density due to interaction 
and/or binding with another molecule, even at the periphery 
of then porphyrin, results in spectroscopic changes. This is 
the physical basis of our porphyrin-based sensor system. 
Detection of Organic Ligands via Reversible 
Competitive Inhibitors 
According to another preferred embodiment, there is 
provided a real-time detector of OP, and other similar 
compounds, that utilizes a reversible competitive inhibitor in 
combination with spectrographic analysis of at least two 
different light wavelengths. By way of summary, in the 
preferred embodiment a detector is formed by depositing a 
biochemically active solid-state layer of AChE on a micro-
scope slide as is described below. As a next preferred step, 
a porphyrin is bound at the active site of the AChE molecule, 
which porphyrin is chosen so as to bind weakly to AChE 
and, thus, be subject to displacement by OP compounds. 
Exposure of the AChE/porphyrin detector to OP or similar 
compounds will result in the porphyrin being displaced from 
its location at the active site, thereby resulting in a change 
in the spectrographic properties of the detector. As has been 
discussed previously, the instant invention preferably uti-
lizes real-time spectrographic measurements at light wave-
45 
OP and similar chemicals are present. Of course, when the 
porphyrin is displaced, the spectrum of the biosensor 
changes again. 
For purposes of detection, the spectrum of the AChE/ 
porphyrin complex will preferably have been determined in 
50 advance of its exposure to an unknown, especially at the 405 
nm and 426 nm wavelengths. These spectral values can be 
used as baseline values and compared with the spectral 
values after/during exposure to check for OP compounds. 
Later, when an inhibitor binds with the complex on the 
55 detector, it will displace the poorly bound porphyrin. Evi-
dence of this displacement will be manifest in from an 
increase in the 405 nm spectral band will and a decrease in 
the 426 nm band. Those of ordinary skill in the art will 
recognize that the specificity of the detection method sug-
60 gested herein is twofold. First, only those molecules that are 
specific inhibitors of the enzyme will bind and displace the 
porphyrin. And, second, the spectral wavelengths that are 
monitored are specific for the particular porphyrin used. 
As will be further recognized by those of ordinary skill in 
65 the art, the use of a competitive inhibitor such as that 
described above will result in a porphyrin that weakly binds 
at the same site on the AChE molecule that the substrate 
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acetylcholine, nerve gasses, organophospates, and other 
inhibitors bind. Additionally, when the porphyrin binds to 
AChE, a marked change in the spectrum of the porphyrin is 
observed, since the porphyrin now "senses" the environment 
14 
Preferably, the light that is supplied to the preferred slide 
embodiment, and which is the source of the evanescent 
waves, will be delivered to the detector by way of optical 
fibers according to methods well known to those of ordinary 
5 skill in the art. of the active site of the AChE. Finally, the weakly-bound 
porphyrin is readily displaced from its location on the active 
site either by substrate (acetylcholine) or other inhibitor 
whose binding site is also at the active site since (hence 
making it a reversible inhibitor). When the porphyrin mol-
ecule is displaced, the spectrum of the biosensor will 10 
change, which change can then be detected via spectra-
graphic analysis as discussed previously. 
In conclusion, TPPS1 is an effective competitive inhibitor 
Finally, as has been discussed previously, in the preferred 
embodiment the instant detector will be created on glass or 
similar material that is optically transparent. In light of the 
foregoing, it should now be clear why this arrangement is 
preferred, as it provides a convenient way to generate and 
use evanescent waves when detector materials are read. Of 
course, preferably the glass, plexiglas, etc., will be of a 
density, thickness, and configuration to encourage genera-
tion of such waves. For example, although thin planar pieces 
15 of transparent material such as microscope slides are 
preferred, sections of fiber optic cable which have been 
treated as described previously could alternatively be used. 
of AChE causing a reversible inhibition. Specific spectral 
changes at the 402 nm and 442 nm wavelengths occur in the 
TPPS1 absorbance spectrum when the porphyrin binds to 
AChE. The spectrum of the TPPS1 -AChE complex can be 
altered in the 442 nm region by addition of compounds 
which bind at the active site of AChE, such as AChI and 
tetracaine, and not those which bind elsewhere (procaine). 20 
Although the detector described above could be read via 
conventional reflectance or absorption spectroscopy, 
because of the low concentration of the reagents thereon, an 
alternative method of assessment is preferred. Thus, and 
according to another aspect of the instant invention, there is 25 
provided a method of reading the above-described detector 
via spectroscopy which is performed by "injecting" light 
into the slide upon which the AChE is bound through one of 
its edges, thereby creating evanescent waves which are then 
utilized to read the detector. 30 
By way of general background, it is well known to those 
skilled in the art, that when light is incident on a medium at 
Experimental Results 
The majority of the data described hereinafter were 
obtained using a member of the class of heterocyclic com-
pounds called the porphyrins discussed previously, the water 
soluble tetraphenylporphyrin sulfonic acid (TPPS). The 
spectrum of a typical porphyrin consists of an intense highly 
absorbing "Soret" or B-band in the 400-450 nm region and 
less intense Q-bands in the 500---700 nm (visible light) 
region. Bands in the UV and NIR are present as well, and the 
porphyrins exhibit intense fluorescence. 
There are several lines of experimental evidence that 
clearly indicate that alteration of the UV-VIS spectra of 
porphyrins takes place as a result of interaction with other 
( electron distorting) organics. For example, immobilization 
of porphyrins at a high density on a surface results in 
35 red-shifted peaks and decreased E (absorptivity or extinction 
coefficient) due to ordered stacking of porphyrins such that 
the porphyrin plane is perpendicular to the surface. 
Additionally, the spectrum of free or ( covalently or 
electrostatically) immobilized TPPS is altered by the pres-
an angle of incidence that is greater than the critical angle, 
Snell's law suggests that all of the light will be reflected 
internally at that interface, i.e., total internal reflection will 
occur. However, Fresnel's equations (in concert with Max-
well's equations) predict-and, in fact, it is observed in 
practice-that evanescent waves will be generated at the 
point of total reflection. The energy of this type of wave 
penetrates beyond the surface of the reflecting medium and 
returns to its original medium unless a second medium is 
introduced into the region of penetration of the evanescent 
wave. In other words, if another medium is brought near 
enough to the point where total internal reflection occurs, 
45 
energy in the form of evanescent waves of the same fre-
quency as the incident light will be transmitted to the 
alternative medium. 
40 ence of various chemicals including: 
Of course, if molecules are brought into proximity with a 
surface in which evanescent waves are propagating, the 50 
molecules will interact with those waves and attenuate them 
to the extent that these molecules would absorb the same 
wavelength in conventional light, i.e., in absorption spec-
troscopy. Spectroscopy via evanescent waves is a well 
known method of assessing the composition of low concen- 55 
tration materials, such as those which would be present in 
the preferred embodiment of the instant invention. 
A) Naphthalene. FIG. 1 shows the spectra of TPPS 
immobilized on dialysis tubing (cellulose) in the 
presence/absence of naphthalene. Ligation of naphtha-
lene causes a concentration-dependent loss in 412 nm 
absorbance (loss of TPPS) and an increase in 426 nm 
absorbance caused by the formation of a TPPS-
naphthalene complex. Wavelength maxima changes are 
also observed in the Q-bands (500-700 nm). The 
absorbance changes are linear with the concentration of 
naphthalene present and indicates that concentrations 
equal to or less than 1 ppm (1.7 mM) naphthalene can 
be detected. 
B) Benzene. Complexation of soluble TPPS with benzene 
causes a loss of 413 nm absorbance (TPPS loss) and an 
increase in 419 nm as TPPS is converted to a benzene-
TPPS complex in a concentration-dependent manner. 
In addition, the Q-bands (500-700 nm) ofTPPS in the 
presence of benzene are located at 517,550, 588, and 
646 nm compared to 517, 553, 578, and 635 nm in the 
absence of benzene. 
The spectral changes induced by the presence of naph-
thalene are not the same as those induced by benzene. The 
difference spectra of organic+ TPPS minus TPPS are very 
different for benzene and naphthalene. This indicates that 
Turning now to the preferred embodiment of the instant 
invention, the evanescent waves typically extend about ¼ 
wavelength (e.g., 100-200 nm depending on the wavelength 60 
of the incident light) into the surrounding medium. The 
evanescent light waves penetrate the detector layer on the 
surface of the slide and interact with the chemicals present 
thereon. As described previously, the intensity of light that 
has interacted with the detecting layer is then examined at at 
least two different spectral wavelengths for evidence of the 
presence of an OP compound, e.g., at 405 nm and at 426 nm. 
65 organics can be distinguished from one another on the basis 
of their effect at all five (B and Q) absorbance bands. Each 
organic has its own spectral signature. 
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C) Amino Acids. The spectrum of TPPS is altered by the 
presence of methionine (known to bind porphyrins) and 
tyrosine, tryptophan, and glycine as representative 
amino acids. Different unique patterns of the B- and Q-
spectra (wavelength shifts and changes in intensity) are 5 
observed for each of the 20 amino acids. 
D) Proteins also induce unique spectral changes in TPPS 
as shown in Table 3 presented previously. In the pres-
ence of the protein, a new wavelength given below is 
observed. 
Finally, solid state immobilized porphyrin films can be 
used to detect the presence of aromatic analytes (organics) 
in air. To demonstrate this statement, difference spectra may 
10 
16 
potentially achieved by several means. For example, differ-
ent porphyrins, phthalocyanines, or indicators with higher 
extinction coefficients can be used. Alternatively, it is well 
know that, generally speaking fluorescence is a more sen-
sitive tool than absorbance, typically by an order of mag-
nitude or so ( although the fluorescence bands are very broad 
compared to absorbance). Thus, a small detector incorpo-
rating absorbance as well as fluorescence could increase the 
sensitivity of the. 
Finally, increased sensitivity may be obtained by match-
ing a particular porphyrin to the specific agent that is sought. 
Since the effective sensitivity is related to the extinction 
coefficient of the indicator used, it is possible that it might 
be necessary to construct "designer" porphyrins with 
sidechain substitutions specific for a single analyte (much 
like specific antibodies but with five absorbance bands). 
The Difference Spectrum 
be obtained by first recording the spectrum of the unreacted 
TPPS film. A small amount (about 10 µl) of liquid analyte 15 
(methanol, ethanol, etc) can then be added to the chamber 
and then the spectrum of the film again recorded at different 
time intervals. The spectrum of the unreacted film is then 
subtracted from the reacted film to show the change in the 
spectrum due to exposure to the analyte. 20 
Consider the following simple illustration. If it is assumed 
that an analyte shifts the "-max of a porphyrin from 413 to 429 
nm, for example, the quantitation of the analyte from the 
absolute spectrum of the porphyrin and analyte will require 
that at least 10-20% of the porphyrin be complexed. So, if 
Specificity 
25 
5 mmoles of porphyrin are present on an active detector 
surface, then 1 mmole of analyte must bind before the effect 
can be directly seen in the spectrum of the porphyrin. 
Further, the smaller the wavelength shift, the less sensitive 
the quantitation and the more analyte complex must be 
30 
present to be measured. Thus, detection of low concentration 
compounds poses a significant challenge to analytical meth-
ods that are based on direct measurement and observation of 
the spectrum. 
As shown in Table 2, the changes in the spectrum are 
fairly specific for the analytes used. The utility of the 
porphyrins and related indicators lies in the presence of 
multiple absorbance bands and the fact that an analyte 
affects each of the five bands differently. This is clearly 
indicated in the difference spectra of isopropanol and form-
aldehyde. While all analytes result in an increase in absor-
bance at 421 nm and a decrease at 431 nm (immobilized 
TPPS has it "-max at 431 nm), formaldehyde shows an 
increase in absorbance centered at 513 nm while isopropanol 
shows an increase at 519 nm and noticeable increases at 
around 550 and 580 nm. Changes at 550 and 580 nm are not 
as noticeable in the presence of formaldehyde. 35 
Hence, the instant inventor has determined that it is 
preferable that, rather than attempting to directly detect the 
presence of analyte in the spectrum of the porphyrin, a 
mathematical operation should be performed on the spec-
trum to make clearer the change in that takes place when an 
analyte is introduced into the system of the instant invention. 
Table 2 illustrates the great selectivity and specificity of 
analyte detection due to the increase in absorbance due to 
complex formation in the Soret. It is apparent that some 
analyte-porphyrin complexes have similar wavelengths in 
40 
the Soret band. However, when absorbance as well as 
wavelength differences at the Soret and the Q-bands 1s 
recorded, each analyte is different. 
If an indicator (such as porphyrin) with five bands is 
available and it is assumed that the wavelength in each band 45 
can either increase, decrease, or stay the same, and, further, 
that the intensity at each band can either increase, decrease, 
or stay the same, then there are 56 or over 7700 possible 
permutations of these factors. If the magnitude of wave-
length shift or absorbance changes is specified ( again each 50 
band is independent of the others), the number of 
potentially-detectable analytes increases dramatically. 
That is, a central precept of the instant invention is that the 
preferred method of identifying low concentration com-
pounds is to "continuously" monitor the detector compound 
and to continuously compare the current spectrum with a 
spectrum collected at some previous time. By comparing the 
spectrum at two different points in time, a self-calibrating 
procedure is developed that is much more sensitive than 
other approaches considered heretofore. 
According to a first preferred embodiment, the instant 
method is made more sensitive to low levels of analyte by 
utilizing a difference spectrum, where the spectrum of 
unreacted porphyrin ( or other colorimetric compound) is 
subtracted from its spectrum following exposure to the 
analyte. As shown in FIG. 1, the difference spectrum-
which is computed by subtracting the spectrum of TPPS 
The key to obtaining specificity is to use data from as 
many absorbance bands as possible. Small changes in wave-
length or intensity are easily detected in the difference 
spectrum, which is discussed in below. Most analytes 
present a unique "signature" when all available absorbance 
bands are considered. An indicator with only one absorbance 
band has very limited utility. 
55 alone from the spectrum of TPPS+naphthalene-resembles 
a "1st derivative" function. The absorbance at 413 nm 
decreases due to loss of TPPS when naphthalene binds and 
shifts the wavelength (new peak) to 419 nm. Knowing the 
extinction coefficient of TPPS at 413 nm allows the deter-
Sensitivity 
A primary requirement for effective detection of hazard-
ous agents is that the apparatus and method be able to detect 
(very) low levels of hazardous agents. Not unexpectedly, the 
absorbance changes that would be expected at low concen-
trations are rather small. However, increased sensitivity of a 
detector formed according to the instant invention can be 
60 mination of how much TPPS is lost; this is the same amount 
of TPPS-naphthalene complex formed. 
The presence of low levels of analyte is virtually unde-
tectable except by monitoring the change in the spectral 
characteristics of the detector. Unlike absolute spectra where 
65 the shape and peak wavelength of the spectral curve changes 
with increasing binding of analyte, the "-max and lmin do not 
change; only the absorbance changes with changes in ana-
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lyte concentration. For example, in the presence of increas-
ing benzene, the Soret absorbance band shows only small 
shifts to longer wavelengths since the Soret in the presence 
of benzene is a combination of the TPPS peak at 413 nm and 
the TPPS-benzene peak at 419 nm. The difference spectrum 5 
of these two spectra clearly reveals the loss of absorbance at 
413 and the increase at 419 nm due to benzene complexation 
of only some of the TPPS present. The combination of these 
2 absorbance bands results in the small wavelength shift. 
The magnitude of the wavelength shift will not alter the 
10 
sensitivity of the difference spectrum. The closer the wave-
lengths of the porphyrin and porphyrin-analyte complex, the 
sharper the "1st derivative" appearance of the difference 
spectrum and the more the change in absorbance analyte 
concentration. The farther apart the wavelengths, the 
broader the peak and trough of the difference spectrum. In all 15 
cases, the integrated area under the curve will always be 
proportional to analyte concentration. 
18 
Interaction Time 
The spectral changes observed in porphyrins are typically 
completed within approximately 1 second in both soluble 
(free, aqueous) and immobilized porphyrins. Thus, for 
detection purposes, spectral measurements might be col-
lected at least this often. 
Response to Changing Analyte Levels 
Unless it becomes "saturated", any detector will respond 
to increasing analyte levels. But, it is much less common to 
find a detector that can respond to decreasing levels of a 
compound. However, the instant system is one such detector. 
Decrease in naphthalene and other aromatic levels in the 
presence of TPPS can be detected in the instant system by 
the change in the difference spectrum of analyte plus TPPS 
minus TPPS. As has been discussed previously, the trough at 
413 nm represents the loss of TPPS due to the formation of 
the naphthalene-TPPS complex observed at 426 nm. 
Decreasing the naphthalene concentration by allowing naph-
thalene evaporation from the solution results in a decrease in 
the "depth" of the trough at 413 nm as the analyte complex 
dissociates. Thus, the spectrum reflects a decrease as well as 
an increase in analyte level. The instant inventor has also 
It is important to note that the use of difference spectra to 
detect an analyte-indicator complex also means that the 
sensor and active surface do not need to be calibrated prior 20 
to use and that a partially-used sensor is still completely 
useful. This is so because, first, it is the time-dependent 
change in absorbance and not the absolute amount of 
indicator that is monitored. The loss of TPPS or other 
indicator, for example, can be quantitated from its extinction 
coefficient, the absorbance loss being proportional to the 
amount of porphyrin which reacts with analyte. 
Second, since difference (comparison) spectra are used, a 
spectrum recorded at any previous time can be subtracted 
from the current spectrum to yield a measure of the change 30 
since the earlier reading. For example, the spectrum of the 
film at some arbitrary zero time could be subtracted from the 
spectrum five minutes later after exposure to analyte X. To 
determine if more analyte is present at, say, ten minutes, 
either the zero or five minute spectra could be subtracted. In 35 
the first case (i.e., t=0 subtracted) the total exposure after 10 
minutes is measured; in the second case, only the change 
between t=S and t=lO minutes is recorded. If in the period 
between 5 and 10 minutes analyte Y binds which causes an 
absorbance change at a different wavelength than analyte X, 40 
the difference between the zero and ten minute spectra 
would show a deep trough at the TPPS peak at 413 nm and 
25 shown that removal of analytes from the vicinity of immo-
bilized TPPS surfaces can result in a return to the pre-
exposure spectrum of TPPS; the analyte can dissociate from 
the porphyrin, thereby "regenerating" the indicator material. 
Using Immobilized Proteins as Detectors 
Methods for immobilizing proteins on solid substrate are 
well known to those of ordinary skill in the art. For example, 
antibodies and proteins are immobilized onto 96-well 
ELISA plates either electrostatically or covalently using 
commercially-available products from Corning Costar or 
Xenobond (Saddle Brook, N.J.). Affinity columns are rou-
tinely made by covalent linkage of proteins to column 
matrices such as CN-Br activated Sepharose (Pharmacia) 
and have even been used by this investigator to separate 
organelles. 
Enzymes have been immobilized onto electrode surfaces 
2 peaks at the wavelengths corresponding to the TPPS-X and 
TPPS-Y complexes. The 10 minute minus 5 minute spec-
trum indicates the amount of TPPS that reacted in the 5 45 
or films used in their assembly, just as used in a Clark 
oxygen electrode. As in the case of immobilization for 
ELISA, preservation of the enzyme structure and catalytic 
ability is desirable and imparted by the immobilization. minute period (loss in 413 nm ) and the absorbance increase 
at the "-max of the TPPS-Y component without interference 
by the TPPS-X complex formed previously. In this case, the 
same film can report multiple analytes. Also, the need to 
"calibrate" or use a fresh indicator is unnecessary since 
changes in the absorbance are measured regardless of the 
original intensity of the indicator. 
More generally, it is contemplated by the instant inventor 
that any number of mathematical comparisons between the 
spectra and two different time periods could be used to 
accentuate the change occasioned by the introductions of 
low concentrations of the target compound. For example, in 
some cases taking the ratio of corresponding spectral inten-
sities might be useful. In other cases, ratios ( or differences, 
products, etc.) between the squared, cubed, etc., spectral 
intensities might prove effective. Obviously, many more 
combinations might be devised by one of ordinary skill in 
the art. Thus, for purposes of the instant invention, the term 
"difference" should be interpreted broadly to include any 
mathematical combination of a spectra intensities at one 
period of time with corresponding intensities at another 
period. 
Others have immobilized octopine dehydrogenase and pyru-
vate oxidase to cellulose triacetate ( chitosan) using glutaral-
dehyde to make an octopine sensor (senses Oxygen uptake 
50 via Clark electrode); nucleoside phosphorylase and xanthine 
oxidase to chitosan to make a phosphate, inosine, and 
hypoxanthine biosensor sensor; and ornithine carbamyl 
transferase and nucleoside phosphorylase to cellulose triac-
etate using glutaraldehyde. Still others have immobilized 
55 phosphotriesterase (OP hydrolase) to polyurethane polymer 
using isocyanate cross-linking to generate a protein-filled 
"sponge" used for nerve gas decontamination form surfaces. 
It is also possible to immobilize organophosphate hydrolase, 
acetylcholine esterase, and choline oxidase onto activated 
60 silica gel using glutaraldehyde to produce a biosensor to 
detect OPs like paraoxon; this sensor measures the produc-
tion of colored product from the breakdown of an analog of 
acetylcholine. Additionally, it is known that it is possible to 
cross-link cholinenoxidase and AChE onto a Pt-electrode to 
65 fabricate a sensor to detect the OP dichlorvos (dimethyl 
2,2'-dichlorovnyl phosphate). In summary, the enzymes 
affected by OPs can be immobilized and cross-linked in a 
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variety of ways without loss of specificity or activity and 
with increased stability and active life. 
Using Porphyrins to Detect Conformational 
Changes in Proteins 
It is well known that boiling denatures proteins. As seen 
in FIG. 2, in the presence of native glucose oxidase, only a 
small decrease in absorbance at 412.5 nm is observed. In the 
presence of boiled glucose oxidase, the absorbance decrease 
at 412.5 nm is larger and a new absorbance peak at 423 nm 
is observed (not observed in "normal" glucose oxidase). If 
TPPS were to experience the same environments in boiled as 
in native glucose oxidase, there would be no difference in 
the spectra. A change in spectrum indicates that the porphy-
rin TPPS reflects the change in conformation of the protein 
caused by boiling. 
Trypsin, like AChE, has a serine at the active site that 
reacts with substrate. Trypsin is inhibited by a small 6 
kilodalton protein that, similar to the action of OP with 
AChE, binds at the active site and prevents the binding of 
substrate. The binding of the inhibitor to trypsin alters the 
spectrum of TPPS, as seen in FIG. 3. Trypsin alone causes 
a decrease in absorbance at 411.8 nm as TPPS reacts with the 
protein and absorbs light at a new wavelength 421.5 nm due 
to interaction of TPPS with a region of the protein. The 
inhibitor alone causes the appearance of a peak at 424.7 nm. 
In the presence of both trypsin and its inhibitor, the absor-
bance increase is seen at 421.9 nm. 
20 
indicator of conformational change. This may require the 
use of a porphyrin with different characteristics than TPPS. 
Similar detection can be used to detect the presence of 
inhibitors/substrates/etc of other enzymes and proteins as 
5 well. 
Thus, a key aspect of the instant invention is the detection 
of the presence of cholinesterase inhibitors, nerve agents, 
organophosphates, etc by their binding to the protein ace-
tylcholine esterase or other related ("serine esterase/ 
10 
hydrolase/protease" with a serine in the active site) enzymes, 
altering the conformational change of the protein. Instead of 
measuring the loss of enzymatic activity of acetylcholine 
esterase or serum cholinesterase as is usually done, change 
in conformation of the enzyme by any inhibitor (hence, 
broad spectrum) is measured. The measurement involves the 
15 use of a "reporter" molecule such as a porphyrin whose 
absorbance and/or fluorescence spectrum changes as its 
immediate environment changes. This is a non-specific 
detector of any cholinesterase inhibitor that alters the con-
formation of the enzyme. The specificity of the detection of 
20 only nerve agents relies on the inherent specificity of ace-
tylcholine esterase and OP hydrolases to only bind these 
agents or substrate in the active site to the exclusion of other 
molecules. 
A preferred field of application of the instant methods is 
25 for use with detection of chemical warfare agents. Of course, 
it is impossible in most instances to determine the response 
of the instant invention to lethal chemicals of these sorts. 
However, it is possible to verify the utility of the methods 
disclosed herein through the use of analogues (simulants) of 
organophosphate and sulfur-mustard compounds. For 
example, the absorbance and fluorescence changes of 
soluble and immobilized porphyrins and other colorimetric 
indicators can be measured in the presence of simulant 
compounds such as DIMP, DMMP, MPA, malathion, par-
athion (to simulate organo-phosphate agents such as Sarin or 
VX) and imidazole, methionine, thiodiethanol, cysteine, and 
other sulfur-containing organic molecules (to simulate 
mustards). Further, the absorbance/fluorescence changes of 
porphyrins or other colorimetric compounds associated/ 
incorporated with acetylcholine esterase, OP hydrolase, or 
Another example of inhibitor-induced conformational 
30 
change detected by TPPS is seen in the enzyme glucosidase 
(which breaks down sugars similar to lactose) and its 
competitive inhibitor gluconolactone. In the absence of 
gluconolactone, the wavelength of TPPS is shifted to 423 
nm by glucosidase (FIG. 4); in the presence of gluconolac-
35 
tone and glucosidase, the wavelength maximum is seen at 
425 nm and a loss in 515 nm absorbance (another absor-
bance band of TPPS) is also seen. In addition, the absor-
bance changes are significantly larger in the inhibited 
enzyme. 
40 other model proteins such as "serine esterases" may be used 
to simulate the conformational changes in the protein 
induced by binding of nerve agent/inhibitor. 
Based on the forgoing, the instant inventor contemplates 
that the presence of organophosphates and other nerve 
agents (inhibitors ofAChE) including VX, GA, GB, etc., can 
be detected as a class of nerve agents from the conforma-
tional changes induced by the binding of the inhibitor to 45 
AchE, organophosphate hydrolase (binds OP and catalyzes 
its hydrolytic breakdown), or other enzymes/proteins. Nerve 
agents such as VX are expected to bind at the active site, and 
like paraoxon, induce a conformational change in AChE or 
OP hydrolase. These conformational changes can be 50 
detected by several techniques, as indicated earlier, as well 
as via the following: 
1) the intrinsic fluorescence of tryptophan residues in the 
enzyme might change if/when the hydrophobic/ 
hydrophilic environment of the tryptophan changes as 55 
the conformation of the protein changes; and 
Preferred Embodiments 
When the instant invention is used in practice, the spectral 
measurements might come from either absorbance, 
fluorescence, or reflectance spectra. Where absorbance spec-
tra are used, the preferred range of light within which 
measurements will be taken is the 200---900 nm (UV-VIS) 
range (suitable at least for chemical warfare agents). Further, 
it is preferable that either a dual wavelength or dual beam 
instrument (and procedures) be used. In the preferred 
embodiment, dual beam spectroscopy is performed using a 
Cary 4E UV-VIS instrument. 
When dual wavelength spectroscopy is to be used, a 
conventional dual wavelength spectrophotometer would be 
a suitable instrument. Dual wavelength spectroscopy is 
ideally suited to measuring absorbance spectra of highly 
scattering turbid samples and for spectroscopic measure-
2) changes in the absorbance and fluorescence of mol-
ecules such as porphyrins whose absorbance as well as 
fluorescence spectra changes as the conformation of the 
enzyme changes. 
In general, the spectrum of porphyrins is unaffected by 
inorganic molecules like salts unless they induce "stacking" 
60 ment via fiber optics. Since light is scattered by turbid 
samples, the detector tends to see the "scatter" as "absor-
bance" (decrease in light intensity). Further, since shorter 
wavelengths of light are scattered more than are longer or aggregation (both of which alter the absorbance charac-
teristics and reactive properties of the porphyrin). 
Preferably, a porphyrin that partitions itself into a region of 65 
a protein whose hydrophilic or hydrophobic nature changes 
as the substrate or inhibitor (better) binds is used as an 
wavelengths, the spectrum of a turbid sample in a dual beam 
instrument using water or air as reference has a non-flat 
baseline, making data interpretation difficult if not impos-
sible. 
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Finally, TPPS can be covalently linked to dialysis tubing 
by drying TPPS onto the tubing. The films are washed with 
1 M NaCl. The TPPS that is left bound is not removed by 
acid/base or salt treatment. The absorbance of the bound 
In dual wavelength spectroscopy, two wavelengths of 
light alternately illuminate the sample, one wavelength 
being designated as a reference wavelength. Thus, a refer-
ence material need not be used. Of course, a reference 
wavelength should be chosen so as to not coincide with an 
absorbance peak of the sample. The absorbance of the 
reference wavelength is the "reference" signal of the system 
and includes light losses due to the material of the samples 
5 TPPS is small, but perfectly suited for detection of low 
levels of analyte using difference spectra as described pre-
viously. 
as well as the optical system (including cuvettes, holders, 
optical fibers, etc). Dual wavelength spectroscopy is the 10 
technology of choice when it is necessary to measure 
reflectance spectra, evanescent wave spectra, fiber optically-
coupled samples, or solid/suspension/films/slurries, etc. 
(i.e., high scatter or variable samples, e.g., stirred). 
Fluorescence spectroscopy is also suitable for use with the 15 
instant invention. Of course, it is based on different prin-
ciples than absorbance spectroscopy. As is well known to 
those of ordinary skill in the art, in fluorescence spectros-
copy a photon of light is absorbed and then emitted, the 
emitted photon having a longer wavelength than the photon 20 
absorbed. The time interval between absorbance and emis-
Preferred Apparatus 
Although the instant invention might be embodied in 
many forms: FIGS. 5, 6, and 7 contain some presently 
preferred arrangements. The optical detector of the instant 
invention consists of several elements. First, there is a light 
source that can generate a single wavelength of light (e.g., 
a laser) or more than one wavelength of light (e.g., an LED 
or lamp with/without filters) that illuminates a detector 
surface of the type described previously. The light may be 
shown directly onto the surface or transmitted there via 
some media such as optical fibers (e.g., FIG. 7). Further, the 
wavelength of the incident light can be varied through 
different wavelengths and/or "scanned" across the material 
so that different wavelengths of light are sequentially strik-
ing the material. 
The detector material absorbs different amounts of the 
sion differentiates fluorescence from phosphorescence. The 
emitted photon is of lower energy (longer wavelength), the 
wavelength of emitted light being dictated by the energy 
levels of the electrons of the material. 
Spectral Deconvolution of Multiple Peaks 
25 wavelengths of light falling on it, which produces an absor-
bance spectrum. The light not absorbed by the material is 
transmitted to a detector for measurement. Again, the light 
reflected by the detector material can be directly sensed by The presence of more than one analyte ( a mixture) can be 
detected via the instant methods since it is quite unlikely that 
the analytes will have the same spectral signature. For 30 
example, if the sample is a mixture of naphthalene and 
benzene, a loss would be seen at 413 and a gain at 426 nm 
due to naphthalene and a loss at 413 and a gain at 419 due 
a detector or transmitted to a remote detector. 
The change in light absorbance by the detector surface 
material can be measured via a conventional 
spectrophotometer, where the incident light is scanned 
through many wavelengths and the amount of light is 
to benzene. If the monitoring instrument can optically/ 
spectral resolve these 419 and 426 nm peaks, a trough would 
be seen at 413 nm and peaks at 419 and 426 nm. If the peaks 
cannot be resolved, a peak and a "shoulder" may be seen 
(which analyte is the peak and which is the shoulder depends 
on their relative concentrations). However, both the "-max 
and absorbance of each peak can be determined accurately 
35 
measured at each of these frequencies to yield a spectrum, 
similar to that shown in FIGS. 1 to 4. The scanning spec-
trophotometers can be large bench-based units, "cards" that 
fit into PC's and connect to the detector surface material via 
fiber optics, or via laptop and even smaller computers (such 
40 
as those made by Ocean Optics). 
by calculating the 2nd derivative of the spectra. The wave-
lengths of the peaks will show up as troughs and the depth 
Alternatively, the absorbance at one or two ( or, preferably 
only a few) wavelengths of light can be used to detect the 
presence of one or a few analytes. For example, the presence 
of napthalene causes the porphyrin TPPS to lose its absor-of the trough is proportional to absorbance which is propor-
tional to concentration. 45 bance at 413 nm and to gain absorbance instead at 426 nm. 
Spectra having multiple peaks can be manipulated using 
software such as Grams/32 ( Galactic Industries) for 
subtractions, smoothing, etc. Spectra, including the 2nd and 
4th derivatives or other mathematical manipulations thereof, 
can be performed using any number of available software 
50 
products to determine the wavelengths of peaks and troughs 
and the integrated area under each curve. 
Linkage of Detectors to Solid Substrates 
Porphyrins and proteins are covalently bound to solid 55 
matrices as described earlier. The instant inventor has found 
three preferred approaches to immobilization that have 
yielded a reactive porphyrin surface. The first two methods 
can be used to immobilize proteins. 
First, amino-TPPS can be covalently linked to activated 60 
Sepharose-CH beads with a 9-atom spacer (Pharmacia) 
according to manufacturer's directions. One gram of beads 
is capable of binding 50 mmoles of ligand. 
Second, amino-TPPS is bound to polystyrene microtiter 
plates and microscope slides (Xenobind from Xenopore, 65 
Saddle Brook, N.J.) that exhibit spectral changes on metal 
binding and pH changes. 
In the presence of benzene, the absorbance increases at 419 
nm; different analytes absorb at different wavelengths. To 
determine the amount of napthalene present, only the absor-
bance decrease at 413 nm and increase at 426 nm need be 
measured. 
FIG. 5 diagrams one possible arrangement of a preferred 
detector. The light source should be capable of at least 
emitting light in the general wavelength range shown in 
Table 2. In the preferred embodiment, the light source will 
be an LED or other broad band light source, but it is 
certainly possible that the monochromatic lights sources 
such as lasers could be used instead. What is important, of 
course, is that the light source irradiate the photodetection 
surface with wave lengths of light that at least interact with 
the specific bands of interest. Continuing with the illustra-
tion of the begun previously, the light source should include 
both 413 nm and 426 nm light. 
As is illustrated in FIG. 5, the light will strike two 
photodiodes/phototransistors/photodetectors that are prefer-
ably fitted with narrow filters to admit only light at the 
specific frequencies of interest, i.e., 413+/-3 nm and 426+/-
3-5 nm, respectively, for purposes of the instant example. 
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The colorimetric detector material surface whose wave-
length changes upon reaction with the desired analyte is 
preferably placed between the LED and the detectors. 
Alternatively, the LED light can be reflected (bounced off) 
the material onto the detectors (i.e., a reflectance spectra will 5 
be obtained; the same wavelengths of light will be absorbed 
as in the "head on" configuration.) 
24 
Conclusions 
For purposes of the instant invention a colorimetric 
molecule, indicator, or agent should be interpreted in its 
broadest sense to include a chemical compound which 
changes its color, absorbance spectrum, fluorescence 
spectrum, reflectance spectrum, and/or its fluorescence and 
polarization properties upon binding of or interaction with 
another molecule or atom. This term also encompasses those 
The output current or voltage---0ne can be converted to 
the other-of the detector is proportional to the intensity of 
the light striking it. Thus, in the present example, the output 
of the "413" detector decreases and the output of the "426" 
detector increase as naphthalene binds to TPPS. 
10 molecules whose spectral properties change upon chemical 
oxidation or reduction. For purposes of this disclosure, the 
colorimetric "indicator" can be a colorimetric compound/ 
molecule incorporated into another molecule such as 
protein, DNA, RNA, nucleic acid, amino acid, peptide, etc. 
A simple subtraction circuit using, for example, an opera-
tional amplifier (or "OP amp", FIG. 5) is a preferred 
apparatus for analyzing the voltage difference between the 15 
two signals; the subtraction of a negative voltage ("413") 
from a positive voltage ("426") resulting in an effective 
addition of the two voltage current changes. This arrange-
ment also helps prevents "false" readings. The circuitry can 
be devised to read or detect only when the output of the one 20 
detector goes down and the other goes up. This is a "coin-
cidence" circuit, as both events must occur for the change to 
be registered. The loss of absorbance because of an increase 
in light or the gain in absorbance due to clouding or mud ( or 
whatever) is not recorded. For purposes of the instant 25 
disclosure, the term "comparator" will be taken to include 
not only special purpose hardware for comparing signals 
(such as the differencing units utilized in the preferred 
embodiment), but also will be taken to encompass hardware/ 
software combinations that allow for more elaborate com- 30 
It should further be noted that, although the previous 
discussion has principally been concerned with the real-time 
differencing of spectral intensities using special purpose 
signal processing hardware, the instant invention would 
work in exactly the same fashion if the differencing were 
performed digitally. More specifically, an analog-to-digital 
conversion of the detected spectral intensity signals can be 
performed as the information is collected, with the digital 
output being sent to a microprocessor or a general purpose 
computer ( collectively a "microprocessor", hereinafter) for 
subsequent digital manipulation. Of course, one advantage 
of this arrangement is that any mathematical operation-not 
just differencing----could be used to combine the information 
from the most recently collected spectral values with those 
collected earlier. 
Additionally, in the preferred embodiment the light source 
will contain a plurality of light frequencies therein. Of 
course, those skilled in the art will recognize that, rather than 
using a single broad-band light source, instead two (or more 
parison schemes than differences ( e.g., ratios of signals, 
general linear combinations of signals, products, etc.), 
whether the operation is performed on an analog or a digital 
signal. 
The output from the optical detectors is conventionally a 
voltage, with the voltage being proportional to intensity of 
light in the wavelength monitored which, in turn, is propor-
tional to the amount of analyte that interacts with the 
detector surface. 
35 depending on the application) narrower sources could be 
used instead. 
40 
In the case of a conformational detection system, the loss 
of the 413 nm peak of TPPS and an increase at some other 
wavelength(s) will be recorded as a nerve agent encounters 
the photodetector surface. Use of a proper filter on the 
detector allows only the wavelengths of interest to be 45 
measured. If a filter is used that passes light from, say, 420 
to 430 nm, the wavelengths changes initiated by multiple 
analyte interactions can be recorded. Unlike the case of 
measuring napthalene vs. benzene using TPPS where the 
wavelengths are specific, it is also possible to measure a 50 
change of TPPS absorbance ( or fluorescence) as the enzyme 
conformation changes at whatever wavelength; the speci-
ficity is not in the particular wavelength measured. The 
specificity is introduced into the instant system through the 
fact that the enzyme that will only bind specific inhibitors or 55 
substrates. 
FIG. 6 is a diagram of a fluorescence-based detector 
where the TPPS absorbs light and emits light at, say, 650 nm. 
When the protein shape changes ( as is schematically illus-
trated in FIG. 8) and the TPPS is altered, the fluorescence 60 
wavelengths are also altered to, say, 690 nm. Thus, the 
intensity of the 650 nm fluorescence and the fluorescence 
intensity at 690 nm increases. The circuitry is the same and 
the additive changes are similar. In the preferred 
embodiment, the 650 nm and 690 nm detectors are created 65 
by placing narrow band optical filters of corresponding 
wavelengths ahead of broader band photodetectors. 
It should be further noted that measurement of the loss in 
intensity of the characteristic peak of the AChE-TPPS1 
complex (442 nm) upon introduction of a compound can be 
used to indicate the presence of competitive inhibitors of 
AChE. As described previously, this is especially useful for 
detecting the presence of organophosphates, nerve gases, 
drugs, and pesticides and could possibly be used to detect 
levels of drugs such as tacrine in the body fluids of patients. 
More generally, measurement of the spectral change in the 
TPPS1 -AChE complex provides the basis for a detector for 
any compound which binds at the active site of AChE 
without requiring a measurement of the catalytic activity of 
the enzyme before and after exposure. The same concept 
could be applied to other enzymes which can be shown to 
bind colorimetric molecules such as porphyrins at or near 
the active site. Specific inhibitors of this type of enzyme 
could be detected, provided they cause removal of the 
colorimetric molecule from the active site. 
Finally, the term "real-time" as used herein to describe the 
instant data collection system should be interpreted to 
include times up to about one-minute or so. In general, 
though, the invention is designed to give measure and give 
feedback on the order of a every few seconds. While the 
inventive device has been described and illustrated herein by 
reference to certain preferred embodiments in relation to the 
drawings attached hereto, various changes and further 
modifications, apart from those shown or suggested herein, 
may be made therein by those skilled in the art, without 
departing from the spirit of the inventive concept, the scope 
of which is to be determined by the following claims. 
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What is claimed is: 
1. A method of real-time testing for the presence of an 
analyte in an environment, comprising the steps of: 
26 
(b) exposing said complex to said environment; 
( c) measuring at least one spectral value of said colori-
metric indicator; and, 
( d) determining from any spectral value so measured 
whether said colorimetric indicator has been displaced 
from said binding protein and, thus, whether or not said 
analyte is present within said environment. 
(a) obtaining a colorimetric indicator that has been revers-
ibly incorporated into a binding protein, said binding 5 
protein having an active site at which the analyte will 
bind if present, said colorimetric indicator being a 
porphyrin reversibly bound at said active site to form a 
complex; 9. A method according to claim 8, wherein step (a) 
10 includes the step of immobilizing said complex on a surface. 
10. A method according to claim 9, wherein said surface 
is a microscope slide. 
(b) exposing said complex to said environment; 
(c) measuring at least one spectral value of said colori-
metric indicator; and, 
(d) determining from any spectral value so measured 
whether said colorimetric indicator has been displaced 
from said binding protein and, thus, whether or not said 15 
analyte is present within said environment. 
2. A method according to claim 1, wherein step (a) 
includes the step of immobilizing said complex on a surface. 
3. A method according to claim 2, wherein said surface is 
a microscope slide. 
4. A method according to claim 1, wherein said binding 20 
protein is AChE. 
5. A method according to claim 1, wherein step ( c) further 
includes measuring two spectral values and step (d) further 
includes determining from said two spectral values so mea-
sured whether said colorimetric indicator has been displaced 25 
from said binding protein. 
6. A method according to claim 5, wherein a first of said 
two spectral values is measured at about 402 nm and the 
other at about 442 nm. 
7. A method according to claim 1, wherein step (d) 30 
includes the steps of: 
( dl) obtaining at least one pre-exposure spectral measure-
ment of said colorimetric indicator and said binding 
protein before exposure to the sample, 
( d2) calculating at least one numerical difference between 35 
said at least one measured spectral values and said at 
least one pre-exposure spectral measurements. 
8. A method of real-time testing for the presence of an 
analyte in an environment, comprising the steps of: 
(a) obtaining a colorimetric indicator that has been revers- 40 
ibly incorporated into a binding protein, said binding 
protein comprisingAChE having an active site at which 
the analyte will bind if present, said colorimetric indi-
cator being reversibly bound at said active site to form 
a complex; 
11. A method according to claim 8, wherein two spectral 
values are measured. 
12. A method according to claim 11, wherein a first of said 
two spectral values is measured at about 402 nm and the 
other at about 442 nm. 
13. A method according to claim 8, wherein step (4) 
includes the steps 
( dl) obtaining at cast one pre-exposure spectral measure-
ment of said colorimetric indicator and said binding 
protein before exposure to the sample, 
( d2) calculating at least one numerical difference between 
said at least one measured spectral values and said at 
least one pre-exposure spectral measurements. 
14. A method of real-time testing for the presence of an 
analyte in an environment, comprising the steps of: 
( a) obtaining a colorimetric indicator that has been revers-
ibly incorporated into a binding protein, said binding 
protein having an active sit at which the analyte will 
bind if present, said colorimetric indicator being revers-
ibly bound at said active site to form a complex; 
(b) exposing said complex to said environment, 
( c) measuring at least two spectral values of said colori-
metric indicator, wherein a first of said two spectral 
values is measured at about 402 nm and the other at 
about 442 nm; and, 
( d) determining from said spectral values so measured 
whether said colorimetric indicator has been displaced 
from said binding protein and, thus, whether or not said 
analyte is present within said environment. 
* * * * * 
